Sale of Fangdieckstrasse, Hamburg

Summary by AI BETAClose X

CLS Holdings plc has announced the unconditional exchange of its Fangdieckstrasse property in Hamburg for €25.35 million, a sale price 9% below its latest valuation. The property, comprising approximately 13,116 sqm of office, laboratory, and training space, is nearly fully let with a weighted average remaining lease term of just under seven years. The company has repositioned the site since its 2007 acquisition, transforming it into a life sciences campus. Completion of the sale is anticipated in Q4 2026, with the proceeds designated for debt reduction.

Disclaimer*

CLS Holdings PLC
29 September 2026
 

A red square with white text Description automatically generatedCLS Holdings plc

 

                                                                                   16 Tinworth Street, London

SE11 5AL, UK

  Tel : +44 (0)20 7582 7766

E : enquiries@clsholdings.com

www.clsholdings.com


CLS Holdings plc

("CLS" or the "Group")

 

Sale of Fangdieckstrasse, Hamburg for €25.3 million

 

CLS Holdings plc is pleased to announce the unconditional exchange of Fangdieckstrasse 75, 75a and 75b in Hamburg for €25.35 million, 9% below the latest valuation.

 

The property comprises approximately 13,116 sqm (141,180 sq. ft.) of office, laboratory and training space and is almost fully let, with a weighted average remaining lease term of just under seven years.

 

Since acquiring the property in 2007, CLS has actively repositioned the site through the expansion of laboratory and office space and the agreement of long-term leases, transforming it into a life sciences campus.

 

Completion is expected in Q4 2026 and the proceeds from the sale will be used to pay down debt.

 

Fredrik Widlund, Chief Executive Officer of CLS, commented:

 

"Following the successful repositioning of Fangdieckstrasse, we consider this the right time to dispose of the asset, further focusing our German portfolio and reducing debt. The transformation of the property into an almost fully let life sciences campus demonstrates the value that can be created through active asset management and close engagement with occupiers."

 

- ENDS -

 

For further information, please contact:

 

CLS Holdings plc                                                           

(LEI: 213800A357TKB2TD9U78)

www.clsholdings.com

Fredrik Widlund, Chief Executive Officer

Patrick Symons, Chief Financial Officer

+44 (0)20 7582 7766

 

Panmure Liberum

Jamie Richards

David Watkins

+44 (0)20 3100 2000

 

Berenberg

Carl Gough

Harry Nicholas

+44 (0)20 3207 7800

 

Edelman Smithfield (Financial PR)

Alex Simmons +44 7970 174 353

Hastings Tarrant +44 7813 407 665

cls@edelmansmithfield.com

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

CLS Holdings (CLI)
UK 100